Previous close | 0.4500 |
Open | 0.4500 |
Bid | 0.4000 |
Ask | 0.6000 |
Strike | 42.50 |
Expiry date | 2025-03-21 |
Day's range | 0.4500 - 0.4500 |
Contract range | N/A |
Volume | |
Open interest | 94 |
Kymera Therapeutics (KYMR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
European Commission approves expanded use of Merck's Keytruda in bladder cancer. Sanofi & Lilly announce data from phase III studies on pipeline candidates.
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.